Peripheral Neuropathy in Patients With Colorectal Cancer Receiving Oxaliplatin

被引:58
|
作者
Tofthagen, Cindy [1 ]
McAllister, R. Denise [1 ]
McMillan, Susan C. [1 ]
机构
[1] Univ S Florida, Coll Nursing, Tampa, FL 33620 USA
关键词
III COLON-CANCER; ADJUVANT CHEMOTHERAPY; UNPLEASANT SYMPTOMS; PAIN; NEUROTOXICITY; GUIDELINES; MANAGEMENT; SLEEP;
D O I
10.1188/11.CJON.182-188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuropathic side effects are commonly reported in patients receiving oxaliplatin, but little is known about the characteristics of peripheral neuropathy in this patient population. The purpose of this descriptive study was to explore the prevalence of neuropathic symptoms in patients with colorectal cancer receiving oxaliplatin as well as to explore symptom severity, distress, frequency, and neuropathic interference with activities. Thirty-three patients receiving oxaliplatin at two outpatient facilities completed the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool. Data were analyzed using descriptive statistics. Cold sensitivity, tingling in the hands, and numbness in the hands were the most prevalent neuropathic symptoms, and cold sensitivity, nerve pain, and trouble with balance were the most severe symptoms. Trouble with balance, muscle or joint aches, and neuropathic pain were the most distressing symptoms, and numbness in the fingers and hands and in the toes and feet were the most frequent symptoms. Patients reported that neuropathic symptoms interfered with numerous activities. Oncology nurses can use this information to help educate patients and families about potential side effects of oxaliplatin and to coordinate the care of patients with peripheral neuropathy using a symptom-focused, multidisciplinary approach.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [21] Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
    Griffith, Kathleen A.
    Zhu, Shijun
    Johantgen, Meg
    Kessler, Michael D.
    Renn, Cynthia
    Beutler, Andreas S.
    Kanwar, Rahul
    Ambulos, Nicholas
    Cavaletti, Guido
    Bruna, Jordi
    Briani, Chiara
    Argyriou, Andreas A.
    Kalofonos, Haralabos P.
    Yerges-Armstrong, Laura M.
    Dorsey, Susan G.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (05) : 701 - +
  • [22] Oxaliplatin-Induced Neuropathy in Colorectal Cancer
    Weickhardt, Andrew
    Wells, Keith
    Messersmith, Wells
    JOURNAL OF ONCOLOGY, 2011, 2011
  • [23] A Quantitative Sensory Analysis of Peripheral Neuropathy in Colorectal Cancer and Its Exacerbation by Oxaliplatin Chemotherapy
    Barbosa, Mariana de Carvalho
    Kosturakis, Alyssa K.
    Eng, Cathy
    Wendelschafer-Crabb, Gwen
    Kennedy, William R.
    Simone, Donald A.
    Wang, Xin S.
    Cleeland, Charles S.
    Dougherty, Patrick M.
    CANCER RESEARCH, 2014, 74 (21) : 5955 - 5962
  • [24] The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients
    Robert B. Hines
    Christopher Schoborg
    Timothy Sumner
    Xiang Zhu
    Elizabeth A. Elgin
    Shunpu Zhang
    Supportive Care in Cancer, 2023, 31
  • [25] The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients
    Hines, Robert B.
    Schoborg, Christopher
    Sumner, Timothy
    Zhu, Xiang
    Elgin, Elizabeth A.
    Zhang, Shunpu
    SUPPORTIVE CARE IN CANCER, 2023, 31 (07)
  • [26] Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    El-fatatry, Basma Mahrous
    Ibrahim, Osama Mohamed
    Hussien, Fatma Zakaria
    Mostafa, Tarek Mohamed
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (12) : 1675 - 1683
  • [27] Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    Basma Mahrous El-fatatry
    Osama Mohamed Ibrahim
    Fatma Zakaria Hussien
    Tarek Mohamed Mostafa
    International Journal of Colorectal Disease, 2018, 33 : 1675 - 1683
  • [28] The role of reduced glutathione on oxaliplatin-induced neuropathy in colorectal cancer patients
    Lelli, G.
    Romano, G.
    Ardito, R.
    Bochicchio, A.
    Capobianco, A.
    Coccaro, M.
    Di Leo, P.
    Tartarone, A.
    Romano, C.
    Calvi, N.
    Lorusso, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Effect of reduced glutathione on oxaliplatin-induced neuropathy in colorectal cancer patients
    Giampiero, R.
    Raffaele, A.
    Annamaria, B.
    Alba, C.
    Mariarosa, C.
    Pasquale, D. L.
    Alfredo, T.
    ANNALS OF ONCOLOGY, 2006, 17 : XI66 - XI66
  • [30] Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
    Velasco, Roser
    Bruna, Jordi
    Briani, Chiara
    Argyriou, Andreas A.
    Cavaletti, Guido
    Alberti, Paola
    Frigeni, Barbara
    Cacciavillani, Mario
    Lonardi, Sara
    Cortinovis, Diego
    Cazzaniga, Marina
    Santos, Cristina
    Kalofonos, Haralabos P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (04): : 392 - 398